Compare Agilent Technologies Inc (A) vs Meta Platforms Inc (META) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Meta Platforms Inc — how do they compare? Agilent Technologies Inc trades at $128.42 (market cap $37.04B), while Meta Platforms Inc trades at $604.81 (market cap $1.56T). The key difference: Meta Platforms Inc is far larger — about 42.1× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays the higher dividend (0.78%). Which is the better fit depends on your goals.
| A | META | |
|---|---|---|
Market Cap | $37.04B | $1.56T |
Sector | Health | Media |
52-Week High | $157.20 | $790.00 |
52-Week Low | $110.24 | $525.72 |
Enterprise Value | $38.59B | $1.57T |
Dividend Yield | 0.78% | 0.34% |
Volume | — | 24,093,972 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
META stock trades at $603.37, up 0.51% with a bullish technical signal. Recent quarters show consistent earnings beats, with Q1 2026 EPS of $7.31 exceeding the $6.70 estimate. Revenue grew to $201.0B in 2025, with strong profitability margins. The company launched its Muse Spark AI model, driving positive sentiment, though it faces a youth addiction lawsuit in Massachusetts.
Outlook remains positive with a consensus price target of $826.50, implying significant upside. Key opportunities include AI monetization and revenue growth, while risks involve regulatory lawsuits and high capital expenditures. Analyst consensus is strongly bullish with 79% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →
